ORPH

COM:ORPHAZYME

Orphazyme A/S

  • Stock

DKK

Last Close

1,120.00

23/10 10:25

Market Cap

32.63M

Beta: -

Volume Today

4

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
1.72M
-
3.58M
108.04%
9.08M
153.37%
15.76M
73.66%
9.59M
39.15%
15.52M
61.76%
35.86M
131.12%
26.16M
27.05%
7.14M
72.71%
average receivables
7.14M
-
7.72M
8.06%
12.57M
62.82%
15.33M
21.97%
12.86M
16.10%
14.87M
15.58%
31.14M
109.41%
28.84M
7.38%
8.65M
70.00%
book value per share
7.23
-
1.78
75.39%
50.88
2,757.73%
19.40
61.86%
2.65
86.37%
21.88
726.99%
0.27
98.78%
1.18K
441,718.33%
0.40
99.97%
capex per share
-0.05
-
-0.02
49.89%
-0.12
409.11%
-0.12
4.84%
-0.16
39.91%
-0.18
9.62%
-0.03
84.17%
capex to depreciation
-0.89
-
-0.34
62.27%
-2.38
605.40%
-1.72
27.78%
-0.86
49.70%
-0.98
13.56%
-0.05
94.41%
capex to operating cash flow
0.01
-
0.00
59.22%
0.02
259.28%
0.01
36.04%
0.01
0.58%
0.01
5.86%
0.00
82.57%
capex to revenue
-0.03
-
cash per share
6.64
-
1.46
78.01%
52.20
3,477.87%
19.73
62.21%
6.17
68.71%
25.63
315.22%
2.93
88.57%
1.20K
41,023.33%
0.52
99.96%
days of inventory on hand
days payables outstanding
2.11K
-
days sales outstanding
441.89
-
debt to assets
0.00
-
0.08
-
0.43
448.80%
0.09
79.85%
0.23
168.36%
debt to equity
0.00
-
0.09
-
1.46
1,547.42%
0.11
92.17%
4.28
3,655.54%
dividend yield
earnings yield
-0.06
-
-0.07
26.54%
-0.14
85.13%
-0.26
90.22%
-0.23
10.23%
-0.33
42.92%
-1.05
214.23%
-3.85
268.15%
-0.00
99.99%
enterprise value
-25.73M
-
751.90M
3,022.15%
772.41M
2.73%
294.03M
61.93%
490.68M
66.88%
1.40B
185.99%
1.25B
11.13%
537.02M
56.94%
-11.43M
102.13%
46.95B
410,959.59%
enterprise value over ebitda
-14.31
-
-12.29
14.12%
-2.25
81.66%
-2.13
5.46%
-4.23
98.42%
-2.07
51.12%
-0.87
57.77%
0.29
133.22%
-1.74K
599,060.68%
ev to operating cash flow
-16.20
-
-14.11
12.88%
-3.08
78.17%
-2.09
32.17%
-4.29
105.44%
-2.31
46.12%
-0.89
61.48%
0.10
110.87%
-2.35K
2,420,500.28%
ev to sales
14.84
-
free cash flow per share
-4.58
-
-5.59
22.11%
-8.01
43.29%
-11.85
47.97%
-16.48
39.11%
-19.18
16.37%
-17.28
9.91%
-3.34K
19,251.18%
-0.57
99.98%
free cash flow yield
-0.06
-
-0.07
22.11%
-0.10
49.85%
-0.27
155.81%
-0.23
14.98%
-0.29
25.56%
-1.01
252.26%
-3.80
277.35%
-0.00
99.99%
graham net net
6.06
-
0.67
88.91%
49.31
7,239.64%
17.61
64.28%
0.21
98.79%
18.99
8,819.10%
-0.82
104.34%
1.03K
125,382.78%
0.40
99.96%
graham number
27.53
-
15.36
44.20%
109.26
611.27%
70.78
35.22%
31.67
55.25%
104.82
230.96%
10.39
90.09%
9.49K
91,230.71%
2.59
99.97%
income quality
0.87
-
0.86
0.74%
0.73
15.59%
1.01
39.17%
0.97
4.01%
0.85
12.49%
0.96
12.98%
3.08
220.10%
0.77
75.03%
intangibles to total assets
0
-
0
0
0.01
Infinity%
0.02
63.76%
0.06
139.51%
0.02
74.03%
0.01
17.99%
0
100%
0
interest coverage
167.46
-
-894.65
634.24%
-202.54
77.36%
-67.09
66.88%
-69.95
4.26%
-43.12
38.36%
-66.96
55.30%
interest debt per share
-0.03
-
0.01
123.34%
0.05
640.56%
1.89
3,429.77%
4.09
116.75%
2.99
26.89%
1.42
52.67%
inventory turnover
invested capital
0.00
-
0.09
-
1.46
1,547.42%
0.11
92.17%
4.28
3,655.54%
market cap
819.91M
-
786.76M
4.04%
925.77M
17.67%
885.39M
4.36%
1.45B
63.75%
1.90B
31.29%
599.31M
68.51%
31.04M
94.82%
46.96B
151,224.92%
net current asset value
29.67M
-
69.69M
134.87%
13.46M
80.68%
600.84M
4,363.21%
370.28M
38.37%
20.44M
94.48%
581.70M
2,745.87%
-4.95M
100.85%
41.67M
942.44%
14.24M
65.82%
net debt to ebitda
1.29
-
0.23
82.36%
4.84
2,020.66%
1.71
64.60%
0.14
91.83%
1.09
676.55%
0.10
90.69%
1.08
964.10%
0.42
61.31%
net income per share
-4.66
-
-5.89
26.54%
-10.43
77.03%
-11.47
10.03%
-16.85
46.88%
-22.32
32.45%
-17.94
19.64%
-3.39K
18,779.48%
-0.74
99.98%
operating cash flow per share
-4.53
-
-5.56
22.88%
-7.89
41.70%
-11.73
48.79%
-16.32
39.10%
-19.00
16.44%
-17.25
9.21%
-3.34K
19,283.10%
-0.57
99.98%
payables turnover
0.17
-
receivables turnover
0.83
-
research and ddevelopement to revenue
6.35
-
return on tangible assets
-0.56
-
-1.81
222.94%
-0.19
89.34%
-0.53
175.87%
-1.98
271.86%
-0.78
60.57%
-3.66
368.48%
-2.06
43.88%
-1.35
34.37%
revenue per share
1.04
-
roe
-0.64
-
-3.31
414.17%
-0.20
93.81%
-0.59
188.51%
-6.37
977.42%
-1.02
83.98%
-67.09
6,474.07%
-2.87
95.73%
-1.83
36.20%
roic
-0.64
-
-3.31
417.93%
-0.20
93.84%
-0.54
162.52%
-2.32
332.48%
-0.86
62.82%
-11.26
1,207.87%
-0.92
91.79%
-1.90
105.53%
sales general and administrative to revenue
11.64
-
shareholders equity per share
7.23
-
1.78
75.39%
50.88
2,757.73%
19.40
61.86%
2.65
86.37%
21.88
726.99%
0.27
98.78%
1.18K
441,718.33%
0.40
99.97%
stock based compensation to revenue
0.44
-
tangible asset value
31.55M
-
74.14M
135.02%
17.51M
76.38%
605.85M
3,360.21%
377.50M
37.69%
42.43M
88.76%
608.07M
1,333.12%
7.19M
98.82%
41.67M
479.67%
14.24M
65.82%
tangible book value per share
7.23
-
1.78
75.39%
50.06
2,712.00%
18.87
62.31%
2.12
88.77%
21.44
911.68%
0.21
99.04%
1.18K
573,931.93%
0.40
99.97%
working capital
29.67M
-
69.69M
134.87%
13.46M
80.68%
600.84M
4,363.21%
370.39M
38.35%
82.24M
77.80%
617.04M
650.32%
29.85M
95.16%
41.77M
39.91%
14.24M
65.90%

All numbers in DKK (except ratios and percentages)